RU2003132049A - PHARMACEUTICAL COMPOSITION Possessing Cerebrovasodilating and Nootropic Activity - Google Patents

PHARMACEUTICAL COMPOSITION Possessing Cerebrovasodilating and Nootropic Activity Download PDF

Info

Publication number
RU2003132049A
RU2003132049A RU2003132049/15A RU2003132049A RU2003132049A RU 2003132049 A RU2003132049 A RU 2003132049A RU 2003132049/15 A RU2003132049/15 A RU 2003132049/15A RU 2003132049 A RU2003132049 A RU 2003132049A RU 2003132049 A RU2003132049 A RU 2003132049A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
cerebrovasodilating
nootropic activity
composition possessing
nootropic
Prior art date
Application number
RU2003132049/15A
Other languages
Russian (ru)
Other versions
RU2262931C2 (en
Original Assignee
Закрытое акционерное общество "Канонфарма продакшн" (RU)
Закрытое Акционерное Общество "Канонфарма Продакшн"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое акционерное общество "Канонфарма продакшн" (RU), Закрытое Акционерное Общество "Канонфарма Продакшн" filed Critical Закрытое акционерное общество "Канонфарма продакшн" (RU)
Priority to RU2003132049/15A priority Critical patent/RU2262931C2/en
Priority to EA200501848A priority patent/EA009666B1/en
Priority to PCT/RU2004/000428 priority patent/WO2005041952A1/en
Publication of RU2003132049A publication Critical patent/RU2003132049A/en
Application granted granted Critical
Publication of RU2262931C2 publication Critical patent/RU2262931C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (3)

1. Фармацевтическая композиция в виде твердой лекарственной формы, обладающая церебровазодилатирующей и ноотропной активностью, содержащая винпоцетин и пирацетам в качестве активных ингредиентов и фармацевтически приемлемые носители, при этом содержание активных ингредиентов составляет, г:1. A pharmaceutical composition in the form of a solid dosage form having cerebro-vasodilating and nootropic activity, containing vinpocetine and piracetam as active ingredients and pharmaceutically acceptable carriers, the content of active ingredients being, g: Винпоцетина 0,0045-0,0150Vinpocetine 0.0045-0.0150 Пирацетама 0,36-1,2Piracetam 0.36-1.2 2. Фармацевтическая композиция по п.1, отличающаяся тем, что выполнена в форме капсулы.2. The pharmaceutical composition according to claim 1, characterized in that it is made in the form of a capsule. 3. Фармацевтическая композиция по п.1, отличающаяся тем, что выполнена в форме таблетки.3. The pharmaceutical composition according to claim 1, characterized in that it is made in the form of tablets.
RU2003132049/15A 2003-11-03 2003-11-03 Pharmaceutical composition possessing cerebrovasodilating and nootropic activity RU2262931C2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RU2003132049/15A RU2262931C2 (en) 2003-11-03 2003-11-03 Pharmaceutical composition possessing cerebrovasodilating and nootropic activity
EA200501848A EA009666B1 (en) 2003-11-03 2004-10-29 Pharmaceutical composition exhibiting a cerebral vasodilatation and nootropic activity
PCT/RU2004/000428 WO2005041952A1 (en) 2003-11-03 2004-10-29 Pharmaceutical composition exhibiting a cerebral vasodilatation and nootropic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003132049/15A RU2262931C2 (en) 2003-11-03 2003-11-03 Pharmaceutical composition possessing cerebrovasodilating and nootropic activity

Publications (2)

Publication Number Publication Date
RU2003132049A true RU2003132049A (en) 2005-04-20
RU2262931C2 RU2262931C2 (en) 2005-10-27

Family

ID=34545985

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003132049/15A RU2262931C2 (en) 2003-11-03 2003-11-03 Pharmaceutical composition possessing cerebrovasodilating and nootropic activity

Country Status (3)

Country Link
EA (1) EA009666B1 (en)
RU (1) RU2262931C2 (en)
WO (1) WO2005041952A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2359669C1 (en) * 2007-10-17 2009-06-27 Закрытое Акционерное Общество "Канонфарма Продакшн" Pharmaceutical composition in form of solution for injections, possessing cerebrovasodilating and nootropic activity, and method of its reception
WO2011055383A2 (en) 2009-11-06 2011-05-12 Lyka Labs Limited Intranasal delivery to improve the performance of children suffering from dyslexia
CN111297818B (en) * 2020-04-02 2022-02-22 常州制药厂有限公司 High-drug-loading-capacity piracetam tablet composition and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201674B (en) * 1987-08-26 1990-12-28 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition suitable for curing autoimmune-type leukoencephalomyelitic diseases e.g. sclerosis multiplex
JP2503571B2 (en) * 1988-02-26 1996-06-05 武田薬品工業株式会社 Cerebral circulation metabolism improver
RU2126250C1 (en) * 1997-10-20 1999-02-20 Ставропольская государственная медицинская академия Method of treating psycho-pathological syndromes of boundary level of vasculosclerotic genesis
UA57813C2 (en) * 2000-06-02 2003-07-15 Закрите Акціонерне Товариство "Фармацевтична Фірма "Дарниця" Vinpocetine-containing pharmaceutical composition for improving cerebral blood circulation
UA55983A (en) * 2002-08-07 2003-04-15 Товариство З Обмеженою Відповідальністю Науково-Виробниче Об'Єднання "Фарматрон" Cerebroprotective and nootropic drug nootril in the form of coated tablets

Also Published As

Publication number Publication date
EA200501848A1 (en) 2006-06-30
EA009666B1 (en) 2008-02-28
RU2262931C2 (en) 2005-10-27
WO2005041952A1 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
EP1435240A3 (en) Solid oral dosage form comprising a combination of methformin and glibenclamide
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
CA2320039A1 (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
IT1294760B1 (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL TABLETS ABLE TO RELEASE, ACCORDING TO PREDETERMINABLE SCHEMES, LITTLE ACTIVE INGREDIENTS
EA200400664A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING METHFORMIN AND GLIBENCLAMIDE, APPLIED TO THE TREATMENT OF TYPE II DIABETES
ZA200000169B (en) Process for the preparation of pellets with a content of up to 90 wt.% of a pharmaceutical active ingredient.
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
CA2353693A1 (en) Pharmaceutical composition containing citalopram
RU2003132049A (en) PHARMACEUTICAL COMPOSITION Possessing Cerebrovasodilating and Nootropic Activity
RU2004131213A (en) MEDICINAL FORMS OF TRAMADOL Slow Release
BE2016C017I2 (en)
JP2005525391A5 (en)
RU92004569A (en) PHARMACEUTICAL PRODUCT OF ANTI-STRESS, STRESS-PROTECTIVE AND NOOTROPIC ACTION
RU95121837A (en) PHARMACEUTICAL COMPOSITION HAVING AN IMMUNOMODELING AND HYPOLIPIDEMIC ACTION
RU2003133067A (en) CEREBROPROTECTOR AND STRESSPROTECTOR MEDICINE "NOOTRIL" IN INJECTION SOLUTION
RU2003104538A (en) CEREBROPROTECTIVE AND NOOTROPIC MEDICINE "NOOTRIL" IN TABLETS, COVERED
RU99106460A (en) Powder Mixture
RU2001132735A (en) SOLID MEDICINAL FORM BASED ON CARVEDILOL
RU98115372A (en) MEDICINE "DYNALGIN"
RU2004104603A (en) ANTIFUNGAL PHARMACEUTICAL COMPOSITION
RU97106910A (en) MEDICAL PREPARATION ETHOL
ATE303136T1 (en) ANHYDROUS DOUBLE-COATED TABLET CONTAINING RANITIDINE HYDROCHLORIDE AND COMPOSITION THEREOF
RU2002113960A (en) Solid dosage form based on sulfamethoxazole and trimethoprim